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FACTORS ASSOCIATED WITH TTO UTILITY CHANGES
AMONG OLDER PEOPLE AT VETERAN HOME
Lai KL1, Kao S2
1Institute of Life Science, National Defense Medical Center,Taipei,
Taiwan; 2School of Public Health, National Defense Medical Center,
Taipei,Taiwan
OBJECTIVE: Time-trade-off (TTO) method is an important tool
in health utility measurement but the contribution factors
regarding its change especially on elder remains unclear. Purpose
of this study was to explore the factors associated with TTO
utility changes among old people. METHODS: A total of 288
male veterans aged above 65 years were longitudinally followed
up one year for time-trade-off (TTO) utility. The data on
WHOQOL-BREF (Taiwan version), socio-demographics, health
status, health behaviors, home care, and health perception
including rating scale (RS), self-rating health, and self-rating hap-
piness were also collected. Wilcoxon rank sum test and Spear-
man correlation were used to select candidate of factor. Multiple
regression analysis was performed to explore the contribution
factors with the changes of TTO utility. RESULTS: The mean
[SD] of TTO utility (0–1) for participants was 0.89 [0.25] at
baseline and changed into 0.78 [0.34] after one year. Several
factors at baseline were associated with the changes of TTO sig-
niﬁcantly (p < 0.05) and independently including: age group,
education level, rank when retired from army, stroke, respiratory
diseases, number of ofﬁce visits to a doctor, RS, self-rating
health, physical domain and 9 facets of WHOQOL-BREF. After
considerations of the collinearity of the variables and the sim-
plicity of the models, variables entered in the ﬁnal multiple
regression models were: education level, stroke, RS, and “depen-
dence on medical substances and medical aids” facet of
WHOQOL-BREF (R2 = 0.12). CONCLUSIONS: Several vari-
ables were associated with TTO utility changes signiﬁcantly and
independently among old people at veteran home. Education
level, stroke, RS, and 2dependence on medical substances and
medical aids2 facet of WHOQOL-BREF were associated factors
of TTO utility changes in the ﬁnal regression model. Due to the
large variation of TTO utility changes the percentage of the vari-
ance accounted by the variables was small.
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EXPLICIT INDICATORS TO MEASURE PREVENTABLE DRUG-
RELATED MORBIDITY IN AN ELDERLY POPULATION
Faris RJ
University of Tennessee, Memphis,TN, USA
OBJECTIVE: To develop consensus-approved explicit indicators
of preventable drug-related morbidity (PDRM) and use these
indicators as a quality measure in an elderly population.
METHODS: The Delphi technique was used with a 7-member
geriatric medicine expert panel to come to consensus on explicit
indicators of PDRM in the elderly. The indicators were con-
structed using a pattern of care and an associated outcome. Mea-
surement of PDRM involved application of the indicators to a
large database. Patients eligible for the study were over 65 and
had the MCO Medicare plan for at least 12 months during an
18-month window. The pattern of care and the associated
outcome had to be present in temporal order to be considered a
PDRM event. Risk factors and economic outcomes were mea-
sured as a part of the database analysis. RESULTS: The Delphi
panel came to consensus on 49 indicators of PDRM. There were
11,711 patients eligible for the study in the MCO’s database. Of
those elderly patients who were eligible, 966 (8.2%) had at least
one instance of PDRM. The most prevalent PDRM events cen-
tered around congestive heart failure, asthma, COPD, and GI
bleeding. The presence of PDRM was signiﬁcantly associated
with the number of prescriptions, number of diagnoses, number
of prescribers, and patients over 85. Patients with a PDRM event
used signiﬁcantly more health care resources and cost more to
care for than those without an event ($16,821 versus $3423).
CONCLUSION: This study is important in its development of
explicit indicators for PDRM and linking the presence of the
pattern of care with the corresponding adverse outcome. These
indicators may be used to measure and monitor the performance
of the medication use system and change the delivery system to
improve patient outcomes. These changes may occur at the indi-
vidual patient level or at a system level.
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JUDGMENT RULES IN OLDER ADULTS’ EVALUATIONS OF
DRUG BENEFIT PLANS
Cline RR, Gupta K
University of Minnesota, Minneapolis, MN, USA
OBJECTIVES: The Medicare Prescription Drug, Improvement,
and Modernization Act of 2003 will provide drug coverage to
seniors through a variety of mechanisms, including stand-alone
prescription drug plans. Although these stand-alone plans must
provide a standard minimum beneﬁt package, variation in cost-
sharing and utilization controls is permitted, leading potentially
to a wide variety of plans from which beneﬁciaries might choose.
Thus, it is important for both policy makers and health insur-
ance ﬁrms to better understand the processes seniors use to
choose among drug insurance plans. The objectives of this study
were to assess and compare the use of a compensatory judgment
model with two conﬁgural (conjunctive and disjunctive) judg-
ment models in older adults’ evaluations of drug beneﬁt plans
with varying attributes. METHODS: Three focus groups con-
ducted with a total of 19 members of a local senior advocacy
group suggested that copayment, premium, deductible, formu-
lary use, and mail-service use were relevant plan attributes. A
separate group of 32 seniors judged the suitability of 48 drug
beneﬁt proﬁles based on these attributes using a 5-point Likert-
type scale. Three regression models, approximating compen-
satory, conjunctive, and disjunctive judgments, were ﬁt by
least-squares to each participant’s judgments using plan attrib-
utes as predictors. Reliability of predictions from each model was
assessed by comparison of multiple correlations. RESULTS:
Mean multiple correlations were strong and ranged from 0.782
for the compensatory model to 0.789 for both conﬁgural models
and were statistically indistinguishable. Multiple correlations
were marginally higher for conjunctive or disjunctive models 
for a majority (62.5%) of subjects. CONCLUSIONS: Results
suggest that both compensatory and conﬁgural judgment models
may provide plausible models of information integration in older
adults’ assessments of prescription drug plans. Future research
could use more ﬁne-grained techniques (e.g. process tracing) to
better understand this process.
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PRESCRIPTION DRUG UTILIZATION PATTERNS AND
CHARACTERISTICS FOR A MEDICARE POPULATION IN
MANAGED CARE
Yokoyama KK,Yu W
WellPoint Pharmacy Management, West Hills, CA, USA
OBJECTIVE: To characterize patient demographics and drug
utilization patterns for Medicare programs within a pharmacy
beneﬁts manager. METHODS: Pharmacy claims data from July
1 to September 30, 2003 for several health plans with a total of
255,000 Medicare members were extracted. These health plans
are geographically diverse with different beneﬁt designs in place.
378 Abstracts
Utilization characteristics from a managed commercial health
plan with a 3-tier beneﬁt design were used for comparison. Pre-
scription utilization data statistics such as per member per month
costs and utilization and types of drug used were calculated. The
top ﬁve therapeutic classes ranked by drug cost per member per
month were also identiﬁed and compared. RESULTS: Mail order
penetration was 5.9% with Medicare and 3.6% for commercial
businesses. Mean age of pharmacy utilizers was 73.1 and 50.6
years in Medicare and commercial business, respectively. Generic
utilization was lower for mail order versus retail pharmacies
(46.9% and 54.8% for Medicare and 34.8% and 46.2% for
commercial business, respectively). Prescription volume was 30.8
and 9.4 per member per year in Medicare and commercial busi-
ness, respectively. Mean ingredient cost was lower in Medicare
plans ($43.79 versus $56.68 in commercial business), while
mean copay was higher in Medicare plans ($27.92 versus $20.08
in commercial business). The top therapeutic classes, as ranked
by ingredient cost per member per month, were similar for both
Medicare and commercial businesses. For Medicare business, the
top classes were antihyperlipidemics, antihypertensives, ulcer
drugs, and antidiabetic agents. For commercial business the top
classes were antihyperlipidemics, ulcer drugs, antidepressants,
and antidiabetic agents. CONCLUSIONS: Prescription utiliza-
tion patterns and drug mix for members in Medicare programs
and commercial health plans differed, mainly driven by beneﬁt
design and coverage policy. Understanding of these differences
are essential to effective Medicare pharmacy program design.
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CONTENT ANALYSIS OF PRINT DIRECT TO CONSUMER
DRUG ADVERTISEMENTS TO DETERMINE NUMBER AND
SPECIFICITY OF RISK STATEMENTS
Valluri S
Ohio State University, Columbus, OH, USA
OBJECTIVE: The objective of the current study is to determine
number and the speciﬁcity of risk factors (side effects, speciﬁc
side effects, contra indications, total number of sentences) dis-
closed in a typical direct-to-consumer print advertisement pub-
lished in 2002. METHODS: Content analysis is a research
technique for the systematic classiﬁcation and description of
communication content to certain usually predetermined cate-
gories. All product speciﬁc prescription drug advertisements
appearing in seven consumer magazines from January 2002 to
December 2002 were collected. The sampling of magazines was
purposive. The magazines were selected based upon their circu-
lation and appeal. All the four variables were deﬁned explicitly.
Side effects were deﬁned as any unwarranted secondary and
adverse effects of the drug. Speciﬁc side effects were deﬁned as
those side effects, which were stressed upon, and where more
information was provided. Contraindications were deﬁned as
statements that contraindicate the use of the advertised drug in
speciﬁc populations or situations. The total number of sentences
was deﬁned as the total number of sentences in the print adver-
tisement that contained any of the side effects, speciﬁc side effects
or contraindications. Judges were trained to determine the valid-
ity of operational guidelines. Cohen’s Kappa was used to deter-
mine inter-rater agreement. Each brand name drug advertisement
served as the unit of analysis. Descriptive statistics were the
primary tool for analytical procedures. RESULTS: A total of 349
advertisements were identiﬁed which represented 40 distinct
brand drugs. There was an average of 4.6 side effects per adver-
tisement. Of these, 0.7 speciﬁc side effects were mentioned per
advertisement. Each advertisement contained an average of 1.7
contraindications and 2.55 sentences. CONCLUSION: Adver-
tisements contained only an average of 2.55 risk statements. The
average number of side effects disclosed in a typical advertise-
ment is less than ﬁve. More than half of the advertisements did
not mention speciﬁc side effects.
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AN ASSESSMENT OF THE EFFECT OF DEMOGRAPHICAL AND
SOCIOLOGICAL FACTORS ON INDIVIDUAL RESPONSE TO
DIRECT-TO-CONSUMER ADVERTISING OF PRESCRIPTION
DRUGS
Makin C, Murawski M
Purdue University, West Lafayette, IN, USA
OBJECTIVES: The objective of this study was to investigate the
factors inﬂuencing the relationship between Health Locus of
Control (HLC) and consumer responsiveness to Direct-to-Con-
sumer advertising (RDTCA) of generic and brand name pre-
scription drugs. This study was intended to provide a framework
to aid in the promotion of generic utilization by consumers and
better targeting of consumers by DTC advertisements in a more
cost-efﬁcient manner, thereby reducing health care expenditure.
METHODS: Direct-mail survey was employed for the purpose
of this study, and questionnaires were sent to a simple random
sample of 900 individuals taken from the entire population of
the United States. The survey was designed according to
Dillman’s Total Design Method, and consisted of several vali-
dated scales, such as the Wallston multidimensional HLC scale,
the Health Value scale by Lau et al, some items seeking to estab-
lish consumer RDTCA, and demographic items. RESULTS: A
net response rate of 47.33% was obtained. Regression tech-
niques and ANOVA were the primary statistical tests employed
to address the research questions. The results established that
RDTCA of brand name prescription drugs was signiﬁcantly
related to External HLC orientation, educational level, income,
gender, race and presence of health insurance. The analysis also
showed the existence of statistically signiﬁcant relationships
between RDTCA of generics and educational level, income,
gender and presence of health insurance. The study suggests that
RDTCA of prescription drugs decreases as the level of both edu-
cation and household income increases, and that females are
more likely to respond to DTC advertising. CONCLUSIONS:
Consumer responsiveness to DTC advertising of prescription
drugs can serve as the basis for well-directed DTC campaigns at
target populations. The results provide several variables that can
be used as the basis for market segmentation, which can be useful
for DTC advertising of both brand name and generic prescrip-
tion drugs.
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STOCK MARKET VALUATION AND FIRM-LEVEL
DETERMINANTS OF INNOVATIVE ACTIVITY IN THE
PHARMACEUTICAL INDUSTRY
Skrepnek GH1, Lawson KA2
1University of Arizona,Tucson, AZ, USA; 2University of Texas at Austin,
Austin,TX, USA
OBJECTIVE: The objective of this research was to examine the
relationship between ﬁnancial valuation and both ﬁrm- and
industry-speciﬁc measures of technological change for ﬁrms
